Spectrum Pharma Begins Phase 2 Study Of ZEVALIN Injection - Quick Facts RTT News (RTTNews) - Spectrum Pharmaceuticals (SPPI: News ) announced the initiation of a Phase 2 study evaluating ZEVALIN Injection for intravenous use + rituximab in combination with motexafin gadolinium or MGd in patients with rituximab-refractory low-grade ... Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN in Combination ... |
